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Recent studies indicate that lipid droplets isolated from a variety of different cells are rich in proteins known to regulate membrane traffic.
Among these proteins are multiple Rab GTPases. Rabs are GTP switches that regulate intracellular membrane traffic through an ability to control
membrane–membrane docking as well as vesicle motility. Here we present evidence that the multiple Rabs associated with droplets have a
function in regulating membrane traffic. Droplet Rabs are removed by Rab GDP-dissociation inhibitor (RabGDI) in a GDP-dependent reaction,
and are recruited to Rab-depleted droplets from cytosol in a GTP-dependent reaction. Rabs also control the recruitment of the early endosome (EE)
marker EEA1 from cytosol. We use an in vitro reconstitution assay to show that transferrin receptor positive EEs bind to the droplet in a GTP/Rab-
dependent reaction that appears not to lead to membrane fusion. This docking reaction is insensitive to ATPγs but is blocked by ATP. Finally, we
show that when GTP bound active or GDP bound inactive Rab5 is targeted to the droplet, the active form recruits EEA1. We conclude that the
Rabs associated with droplets may be capable of regulating the transient interaction of specific membrane systems, probably to transport lipids
between membrane compartments.
Published by Elsevier B.V.Keywords: Membrane traffic; Endosome; Rabs; Adiposomes; Lipid droplets1. Introduction
Scientists have variously designated sites of lipid accumula-
tion in cells as lipid droplets, lipid bodies, lipid inclusions, oil
droplets and oil bodies, which reflects the view that these are
simple lipid storage compartments [1,2]. Recent proteomic,
lipidomic and genetic evidence suggests, however, that these
sites are metabolically active organelles with essential roles in
cell signaling, membrane traffic and lipid homeostasis. Nearly
all prokaryotic and eukaryotic cells are able to store lipids.
Moreover, sites of lipid accumulation are associated with
specific membrane systems. In eukaryotic cells, lipid accumula-
tion appears to be associated with endoplasmic reticulum (ER)
membranes [3] while in prokaryotic cells special regions of the
plasma membrane are involved [2]. Therefore, cells appear to
have special compartments that contain the molecules necessary⁎ Corresponding author. Tel.: +1 214 648 2346; fax: +1 214 648 7577.
E-mail address: richard.anderson@utsouthwestern.edu (R.G.W. Anderson).
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doi:10.1016/j.bbamcr.2007.02.004to synthesize and degrade specific classes of lipids as well as
manage the traffic of these lipids among membrane systems.
For this reason, we have proposed the name adiposome to
designate a cellular compartment specialized for packaging and
distributing various lipids [4]. The lipid droplet in this
nomenclature is a lipid filled adiposome.
The adiposome hypothesis predicts that in eukaryotic cells
portions of the ER are specialized for both accumulating lipids
and distributing them among various membrane systems. They
may also be involved in distributing specific classes of proteins
[5]. Although lipid droplets seem an unlikely target for
membrane traffic because they lack an intact lipid bilayer, the
proteins they contain suggest otherwise. These include: TIP47
[6], a protein involved in mannose-6-phosphate receptor traffic
[7]; p22, a calcium binding protein implicated in exocytosis [8];
PKD2, a kinase that regulates Golgi–plasma membrane traffic
[9]; the caveolar membrane protein caveolin-1, which may
transport newly synthesized cholesterol to caveolae [10] as well
as lysosomal cholesterol to the adiposome [11]; and multiple
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function of these proteins is unclear, it is possible they are
linked to the traffic of essential lipids needed for proper
membrane function. For example, cholesterol regulates the
traffic of the mannose-6-phosphate receptor between the
lysosome and the Golgi apparatus [12] through the activity of
NADH sterol dehydrogenase-like protein (NSDHL), which is
localized to lipid droplets [6] but can traffic to the Golgi
apparatus [13]. Sterols are also critical for the traffic of the yeast
tryptophan transporter Tat2 to the plasma membrane [14]. The
availability of stored or newly synthesized fatty acids generated
by acetyl Co-A carboxylase, another class of lipid droplet-
associated enzymes [4], is linked to the acylation of proteins
involved in yeast vacuolar traffic [15] as well as the main-
tenance of the nuclear envelope [16]. Thus, feedback loops
appear to exist between the lipids synthesized and stored in
droplets and specific membrane systems that carry cargo around
in the cell.
An unexpected family of proteins in the adiposome proteome
is the Rab GTPases [4]. We detected 9 different Rabs by mass
spectrometry and four of these were confirmed by immunoblot-
ting. The presence of these Rabs suggests lipid droplets play a
central role in membrane traffic. Indeed, overexpression of
Rab11 impairs the movement of endosomal cholesterol to sites
of cholesterol esterification [17], which appears to take place in
droplets [18]. In addition, microinjected Rab GDP-dissociation
inhibitor [19] blocks mobilization of endosomal cholesterol.
Finally, Rab18 appears to regulate the interaction of ER with
lipid droplets [20] as well as the level of neutral lipid in the cell
[21]. Here we present evidence that Rabs regulate the
interaction of early endosomes with lipid filled adiposomes.
2. Materials and methods
2.1. Materials
pAb α-caveolin-1, mAb α-EEA1, mAb α-Rab4, mAb α-Ral B and mAb α-
Rab5 were from BD Biosciences (San Jose, CA). pAb α-Rab11 and mAb α-
transferrin receptor were from Zymed Laboratories Inc. (San Francisco, CA).
mAb α-ADRP was from Research Diagnostics Inc. (Flanders, NJ). pAb α-
Rab18, pAb α-Rab5, and DNAse I-protease inhibitor cocktail set III were from
Calbiochem (La Jolla, CA). pAb α-Myc from Upstate (Charlottesville, VA).
Alexa labeled second antibodies were from Molecular Probes (Eugene, OR).
Bovine liver Rab GDP-dissociation inhibitor (lot #090K4116), PMSF and all
nucleotides were from Sigma (St. Louis, MO). Calf serum, fetal bovine serum
and DMEM were from Hyclone (Logon, UT).
2.2. Cell culture
CHO K2 cells were cultured in 150 mm dishes in high glucose DMEM
containing 10% calf serum, 40 μg/ml proline, 100 U/ml penicillin, and 100 μg/
ml streptomycin. The cells were either grown until confluent for droplet
isolation or to 60% confluent for use in isolating endosomes. HeLa cells were
grown overnight in high glucose DMEM with 10% fetal bovine serum and
antibiotics were cultured in 12-well plates (seeded at 50,000 cells/well)
containing a coverslip and grown over night before transfection.
2.3. Lipid droplet purification
Lipid filled adiposomes (designated droplets) were purified as previously
described [4] with several modifications designed to increase the purity. Briefly,10, 150 mm dishes of cells were collected by scraping in ice-cold PBS, re-
suspending in buffer A (25 mM Tricine, pH 7.6, 250 mM sucrose), and
homogenizing by N2 cavitation (450 psi for 15 min on ice). A post-nuclear
supernatant fraction was obtained by centrifugation at 1000×g and loaded into a
SW41 tube. This sample was centrifuged at 274,000×g for 1 h at 4 °C. The white
band (droplet fraction) at the top of gradient (∼0.5 ml) was collected and re-
suspended in 6 ml of buffer A in a SW41 tube. The droplet fraction was overlaid
with 4 ml buffer B (20 mM HEPES, pH 7.5, 100 mM KCl, 2 mM MgCl2) and
centrifuged at 274,000×g for 1 h at 4 °C. The droplet fraction from this spin
(∼0.5 ml) was collected, transferred to an Eppendorf tube and centrifuged at
20,000×g for 4 min. The clear buffer underlying the white band was removed,
the droplets resuspended in 200 μl of buffer B and centrifuged again. This step
was repeated a total of 4 times. The droplet fraction was resuspended in 1 ml of
buffer B, vortexed to resuspend the droplets, subjected to a second round of
washes and finally centrifuged at 265,000×g in a TLA 100.3 tube for 5 min to
remove any contaminating membranes as previously described [4].
2.4. Endosome purification
CHO K2 cells at ∼60% confluency were washed twice with ice-cold PBS
and detached gently from the dish using a cell scraper. Cells from 6, 100 mm
dishes were pooled into one 15 ml tube and spun for 5 min at 500×g at 4 °C.
After removing the supernatant, cells were resuspended in 600 μl buffer C
(250 mM sucrose, 3 mM imidazole, pH 7.4 containing 1/1,000 dilution of
protease inhibitor cocktail set III) and incubated on ice for 20 min. Cells were
then broken using a 22.5 gauge needle. Breaking efficiency was determined by
phase contrast microscopy. Unbroken cells and nuclei were removed by
spinning for 10 min at 1000×g at 4 °C. The pooled post-nuclear supernatant
fraction (PNS) from 30, 100 mm dishes was transferred to the bottom of a
centrifuge tube (volume: 38 ml) and adjusted to a sucrose concentration of
40.6% using a stock solution of 62% sucrose, 3 mM imidazole, pH 7.4. The
sucrose concentration was determined with a refractometer. The solution was
then carefully overlaid with 12 ml of 35% sucrose, 3 mM imidazole, pH 7.4,
followed by 8 ml of 25% sucrose, 3 mM imidazole, pH 7.4 and filled to the top
with buffer C. Gradients were centrifuged at 108,000×g in a swinging bucket
rotor for 3 h at 4 °C. Avisible 25–35% interphase enriched for endosomes (early
and recycling endosomes) was collected [22,23]. Fractions were used directly or
snap-frozen in liquid nitrogen and stored for up to 2 months at −80 °C.
2.5. Preparation of Rab GDP-dissociation inhibitor
In some experiments we used commercial RabGDI and in others we used
recombinant protein purified in the laboratory. For the latter, we used E. coli
strain BL21 (DE3) expressing a His-tagged, bovine RabGDI in a pRESET
plasmid, which was kindly provided by Dr. Oliver Ullrich, Hamburg, Germany.
Bacteria were grown under standard conditions and processed to lyse the
bacteria by freeze–thawing in buffer D (50 mM Na2HPO4, pH 8.0, 0.3 M NaCl,
10 mM 2-mercaptoethanol) containing 1 mg/ml lysozyme and 5 μg/ml of
DNase I-protease inhibitor cocktail III. The suspension was incubated on ice for
30 min and then sonicated on ice 15 times for 30 s each at 50 Joule Watt-sec
before centrifuging for 1 h at 60,000×g at 4 °C to remove the cell debris. To
purify the His-tagged protein, 45 ml of the supernatant fraction was mixed with
1.5 ml of Ni-NTA beads (Qiagen, Valencia, CA) that had been pre-equilibrated
in buffer D containing 10 mM imidazole. The suspension was rotated on a
wheel at 4 °C for 1 h. The beads were spun down at 1000×g for 2 min and
washed (re-suspend and pellet again) three times with 40 ml of buffer D
containing 10 mM imidazole, pH 8.0; three times with 40 ml of buffer D
containing 10 mM imidazole, 0.3% Triton X-100, pH 6.0; and two times in
40 ml of buffer D containing 10 mM imidazole, pH 8.0. Beads were loaded onto
a 10 ml Poly-Prep chromatography column (Bio-Rad, Hercules, CA), washed
with 10 bed volumes buffer D containing 10 mM imidazole, pH 8.0, and finally
eluted with 20 ml buffer D containing 200 mM imidazole, pH 8.0. Fractions
(1.5 ml) were collected and the fractions with the most protein pooled and
dialyzed overnight at 4 °C with 3 times buffer change against buffer E (20 mM
HEPES, KOH, pH 7.2, 10 mM DTT) in Pierce Dialysis cassettes (Rockford, IL)
that had a molecular weight exclusion<10,000, and stored at −80 °C. Pooled
samples were separated by gel electrophoresis and the purity checked by
Coomassie blue staining.
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To remove Rabs from purified droplets or endosomes, each was incubated in
the presence of 2 mM GDP and 10 μM RabGDI in buffer B at 37 °C for 1 h. At
the end of the incubation, the droplets were separated from the incubation
mixture by flotation and the endosomes by sedimentation, all at 20,000×g for
5 min. Both the droplets and the endosomes were washed three times with buffer
B and either analyzed directly or used in the various experiments.
2.7. Recruitment assay
The basic recruitment assay used droplets, endosomes and cytosol all purified
from CHOK2 cells. To measure recruitment of molecules from the cytosol, 50 μl
(∼20 μg of protein) of droplets or liposomes were mixed with 100 μl of cytosol
(∼80 μg protein) in buffer B containing the indicated nucleotide for 1 h at 37 °C.
At the end of the reaction, the droplets or liposomes were separated from the
cytosol, washed and processed for immunoblotting to detect the indicated
proteins. The same general protocol was used to study membrane recruitment.
Droplets (50 μl) were mixed with 50 μl endosomes (100 μg/ml) in buffer B and
incubated at 37 °C for 1 h in the presence of the indicated nucleotide and cytosol
concentration. In some experiments, the droplets were pre-incubated in the
presence of GTPγs. At the end of the incubation, the droplets were separated from
the cytosol and endosomes by centrifugation at 10,000×g. To remove non-
specifically bound endosomes, the droplets were subsequently washed three
times by repeated resuspension of the droplet fraction in buffer B and
centrifuging again at 10,000×g. The lower g force was necessary to retain
endosomes on the droplets during the separation and wash steps.
2.8. Electron microscopic immunogold labeling
Isolated droplets suspended in 200 μl of buffer B was mixed with 200 μl of
6% paraformaldehyde in buffer F and incubated for 1 h at room temperature. The
fixed sample was washed by flotation (20,000×g for 3 min) with buffer B three
times, 5 min each at room temperature, resuspended in 50 mM NH4Cl in buffer
B for 10 min, and washed again with buffer B two times, 5 min each. The sample
was mixed with buffer B containing 0.15% crystallized BSA (buffer F) and
incubated for 30 min at room temperature. Buffer F was removed and the sample
of droplets mixed with either pAb α-Rab5, pAb α-Rab11, or pAb α-Rab18,
diluted 1:25 with buffer F, or 10 μg/ml rabbit IgG in buffer F and incubated
further for 15 h at 4 °C. The droplets were washed by flotation with buffer F and
mixed with goat α-rabbit IgG conjugated to 10 nm gold diluted 1:30 in buffer F
for 2 h at room temperature. Droplets were washed again three times, 5 min at
4 °C. Finally, samples were washed with buffer G (0.1 M sodium phosphate,
3 mM KCl and 3 mMMgCl2 pH 7.6), fixed with 1% GTA and post-fixed in 1%
OsO4, all in buffer G. Samples were embedded in Epon and viewed with a JEOL
1200 electron microscope.
2.9. Targeting Rab5 to droplets
cDNAs were constructed in pcDNA3.1Myc/His that code for Q79L (GTP-
bound) or S34N (GDP-bound) Rab5 lacking the C-terminal CAAX box and fused
at the N-terminus to the first 73 amino acids of AAM-B (GI 89145417). The N-
terminal fusion targets proteins to the droplet [24]. HeLa cells cultured on
coverslips were transfected with the cDNA for either the Rab5 GTP or Rab5 GDP
chimera protein using Fugene 6 according to themanufacturer's protocol, and then
cultured for 4–6 h before changing to media containing 100 μM oleate and
incubating an additional 15 h to cause lipid accumulation in adiposomes. The cells
were then washed, fixed in 3% paraformaldehyde in phosphate buffered saline,
permeabilized with 0.1% Triton X-100 and processed for indirect immunofluo-
rescence to localize the indicated protein using pAb α-Myc (1:300) for Rab5 and
mAb α-EEA1 (1:200). Cells were viewed using a Zeiss Axioplan 2E fluorescence
microscope fitted with a Hamamatsu monochromatic digital camera.
2.10. Preparation of liposomes
Liposomes were made using the method of Grüner et al. [25]. Briefly, lipids
were extracted by the method of Bligh and Dyer [26] from 1/4 of the totalmembrane pellet obtained during the standard preparation of droplets. The
solvent was removed from the lipids using a rotary evaporator followed by
20 min under low torr vacuum. Diethyl ether (5 ml) and buffer B (300 μl) were
added to the lipid film. The ether was driven off under a stream of nitrogen with
bath sonication. The resulting concentrated liposomes were diluted with 1.7 ml
of buffer B and drawn through a 22 gauge needle three times.
2.11. Immunoblotting
Droplets were processed to detect the indicated protein by precipitating
proteins with 1 ml of 100% acetone, dissolving the sample in SDS PAGE sample
buffer, separating them by gel electrophoresis (8% gels for EEA1 and 12% for
other proteins) and transferring to PVDF membranes for immunoblotting.
Immunoblotting was carried out using ECL reagents as previously described [4].
3. Results
Previously we identified nine different Rab GTPases in the
partial proteome of lipid filled adiposomes isolated from CHO
cells [4]. Other proteomic studies have also found Rabs in
droplets isolated from several different cell types [27,28]. We
focused our attention on Rab5 and 11 because they have clear
roles in regulating membrane traffic and 18 because it has been
implicated in droplet interaction with the ER. Commercial
antibodies against these three proteins each immunoblot a single
band of the correct molecular weight (Rab5, ∼28 kDa; Rab11,
∼28 kDa; Rab18, ∼23 kDa) in fractions of purified droplets
(Fig. 1B–D, IB). Immunogold labeling with these antibodies
show gold particles primarily on the surface of both large and
small droplets (arrows, Fig. 1B–D, Immunogold). Membrane
contaminants were rarely seen in these fractions. Gold labeling,
however, is heterogeneous. For example, pAb against Rab5 (B)
appear to label the smaller droplets (⁎) more heavily than the
larger ones, which suggests they contain a higher concentration
of the protein. No labeling is seen with non-immune antibody
(A). We conclude that these three Rabs are associated with the
surface of purified droplets.
3.1. Removal and recruitment of Rabs from purified droplets
Rabs are prenylated proteins that dynamically associate with
various membrane systems. RabGDI (Rab GDP dissociation
inhibitor) is a cytoplasmic protein that releases membrane-
associated GDP bound Rabs, by binding the hydrophobic
geranylgeranyl group, and effectively solubilizes the protein in
a cytosolic complex [29]. We tested the ability of purified
RabGDI to remove Rabs from purified CHO cell droplets (Fig.
2A). We purified droplets, incubated them in the presence (lane
2) or absence (lane 1) of purified RabGDI before separating the
droplets from the incubation mixture by flotation and proces-
sing each for immunoblotting. After RabGDI treatment, nearly
all of the Rab5 and Rab11 (lane 2) were in the incubation
solution (lane 4), indicating they had been extracted. Most of
the ADRP and all of the caveolin-1, by contrast, remained with
the droplets. Loss of ADRP was independent of RabGDI
(compare lane 3 with 4). To see if RabGDI preferentially
removed GDP bound Rabs (Fig. 2B), we looked at the effects of
non-exchangeable analogs of GTP and GDP on extraction.
RabGDI failed to extract Rab5 from droplets that had been pre-
Fig. 2. GDP-dependent removal of Rab from droplets by RabGDI. Purified
droplets (50 μl, ∼20 μg protein/reaction) were incubated in the presence or
absence of 10 μM RabGDI plus 2 mM of the indicated non-exchangeable
nucleotide at 37 °C for 1 h. At the end of the reaction, the droplets were
separated from reaction solution by flotation, washed 3 times, the proteins
precipitated by acetone and processed for immunoblotting. (A) RabGDI
transfers Rab5 and 11 from droplets (Drop) to the reaction solution (Sol). The
loss of ADRP occurs in buffer alone. Caveolin-1 is not removed. (B) RabGDI
cannot remove Rab5 when GTPγs is in the reaction mixture. Ral B, another
prenylated protein, and caveolin-1 are not removed under any condition.
Fig. 1. Multiple Rab proteins are on the surface of lipid filled adiposomes.
Purified droplets were processed either for immunoblotting (IB) or immunogold
localization of the indicated Rab protein (Immunogold). For immunogold,
samples were fixed and incubated in the presence of rabbit IgG (A), pAb α-Rab5
(B), pAb α-Rab11 (C), or pAb α-Rab18 (D). The samples were then incubated
with the α-rabbit IgG conjugated to 10 nm gold. Gold particles (arrows) are
distributed on the surface of the droplet. An asterisk indicates clusters of small
droplets. Immunoblotting shows that each antibody recognizes a single band.
Bar, 0.5 μm.
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GTP (compare lanes 2 and 3). By contrast, Rab5 was efficiently
removed if the GTPγS was replaced with GDPβS (lane 4). ATP
also did not block RabGDI removal of Rab5 (lane 5). RabGDI
did not remove prenylated Ral B under any conditions,
indicating that RabGDI specifically works on Rabs. These in
vitro results suggest that Rabs may be able to cycle on and off
droplets in the cell, and that their interaction with the droplet is
not due to a non-specific binding of the prenyl group. Moreover,
the ability of Rab GDP-dissociation inhibitor to release these
Rabs indicates they are prenylated.
The soluble Rab/RabGDI complex is recruited to membranes
in a multistep process that involves: (a) targeting to a specific
membrane system by unidentified targeting factors [29]; (b)insertion of the Rab prenyl group into the membrane; (c)
dissociation of the RabGDI [30] and (d) exchange of GDP for
GTP mediated by an exchange factor. Recruitment is dependent
on temperature and GTP. Having established that RabGDI
removes GDP bound Rabs, we set out to determine if cytosolic
Rabs can be recruited back to purified droplets under these
physiological conditions (Fig. 3). We first looked at the
nucleotide requirement (Fig. 3A). We purified droplets and
processed them to remove Rabs with RabGDI as described
above. We then mixed them with cytosol plus or minus GTPγs
(lanes 2 and 1, respectively) and incubated for 1 h at 37 °C
before separating the lipid droplets from the cytosol by
flotation, washing and processing them for immunoblotting to
detect Rabs 5, 11 and 18. The presence of GTPγs stimulated the
appearance of both Rabs 5 and 11 in the droplet fraction
(compare lane 2 with 1). The amount of Rab18 in the fractions
remained unchanged under all experimental conditions we
tested. If we pretreated the droplet fraction with GTPγs and then
incubated with cytosol in the absence of nucleotide, neither
Rab5 nor 11 was recruited to the droplet (lane 3). GTPγs had to
Fig. 3. GTP-dependent recruitment of Rabs from cytosol to droplets (A–C) but
not to liposomes (D). Rab proteins were released from droplets (A–C) with
RabGDI as described in Fig. 2. Droplets (50 μl, ∼20 μg protein/reaction) were
mixed with either 80 μg of cytosol (A) or varying amounts of cytosol (B–C) in
the presence or absence of 2 mMGTPγs. After incubation, droplets were washed
three times and the proteins precipitated by acetone and processed for
immunoblotting with an antibody against the indicated protein. (A) GTPγs
pre-bound to droplet is not sufficient to recruit Rabs and EEA1 to droplets.
Droplets were either not treated (1,2) or pretreated with GTPγs and mixed with
cytosol in the presence or absence of GTPγs at 37 °C for 1 h. (B) Rab recruitment
is dependent on temperature and cytosol concentration. Incubations were carried
out at 4 °C and 37 °C with either 0, 400 μg/ml or 800 μg/ml of cytosol (volume
100 μl). (C) Recruitment of Rabs and EEA1 appears to be saturable. Incubation
was carried out at 37 °C with the indicated concentration of cytosol (volume
100 μl). (D) Rabs are not recruited to liposomes. Liposomes were prepared using
lipids extracted from total CHO K2 cell membranes and mixed with 80 μg/ml of
cytosol and incubated at 37 °C for the indicated time. A companion set of
droplets that had not been treated with RabGDI were processed the exact same
way.
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occur. We also found that the Rab5 effector EEA1 (early
endosome antigen 1) is recruited to isolated lipid droplets and
that recruitment is dependent on GTPγs (Fig. 3A). Rab
recruitment is also temperature dependent (Fig. 3B). When
Rab-depleted droplets are incubated in the presence of differentconcentrations of cytosol at 37 °C (lanes 4–6), Rab5 and 11 (as
well as Rab4) are robustly recruited to droplets. By contrast,
very little recruitment occurs at 4 °C (lanes 1–3). Recruitment
of Rabs 5 and 11 appears to be dependent on the concentration
of cytosol in the incubation mixture (Fig. 3C). Above∼1 mg/ml
of cytosol, the concentration of these two Rabs in the droplet
fraction appeared to plateau, suggesting that there may be a
limited number of Rab binding sites on the droplet. In addition
to Rab5 and 11, association of EEA1 with the droplet also
appears to be dependent on cytosol concentration. ADRP,
caveolin-1 and Rab18 were unchanged under all conditions.
Finally, liposomes prepared from lipids that we extracted from a
CHO cell total membrane pellet could not substitute for the
droplets in the Rab recruitment assay (Fig. 3D). These results
suggest that adiposomes contain the molecular machinery
required to recruit Rabs from the cytosol.
3.2. Rab-dependent interaction of early endosomes (EE) with
droplets
The flotation properties of the purified droplets offer the
opportunity to explore the possibility that Rabs regulate the
interaction of adiposomes with a specific membrane system. We
chose early endosomes as the membrane system to study for
three reasons; we detected Rab-dependent binding of EEA1 to
droplets (Fig. 3), there are several membrane markers specific
for this compartment and methods are available to partially
purify endosomal membranes from tissue culture cells [22]. We
mixed purified droplets either with buffer alone (Fig. 4A
lane 1), 5 μg of EE (lane 2), EE plus 2 mM GTPγs (lane 3), EE
plus 100 μl of cytosol (lane 4) or EE plus cytosol and 2 mM
GTPγs (lane 5) and incubated for 60 min at 37 °C. The droplets
were re-isolated and washed by flotation and processed for
immunoblotting. Isolated droplets alone contained Rab5 and 11
but no EEA1 or transferrin receptor (lane 1). Droplets mixed
with EE alone contained a small amount of transferrin receptor.
The addition of GTPγs, by contrast, caused a marked increase in
the amount of both EEA1 and transferrin receptor. We estimate
that under these conditions ∼25% of the transferrin positive
membranes in the mixture become associated with the droplets.
The addition of cytosol to the mixture had little effect on the
amount of EEA1 and transferrin receptor that bound to droplets.
In addition, the amount of EE binding to the droplets appeared
to be saturable (B), which suggests there are a limited number of
binding sites on the droplet. We conclude that EE can interact
with the droplet in a GTP-dependent process that does not
require cytosolic factors.
Since the interaction of EE with the droplets does not require
the addition of cytosol, we were interested in determining if
droplets pretreated with GTPγs will interact with isolated EE in
the absence of GTPγs in the incubation mixture (Fig. 4C). We
pre-incubated one set of isolated droplets with buffer alone
(lanes 1, 2) and another with buffer plus GTPγs (lanes 3, 4) at
37 °C. We washed the droplets, and mixed each set with isolated
EE in the presence or absence of additional GTPγs before re-
purifying the droplets and processing them for immunoblotting
to detect EEA1. Droplets pre-incubated with GTPγs supported
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(compare lane 1 with 3). Moreover, adding the GTPγs to the
mixture did not cause further EE recruitment. These results
suggest that the GTP bound Rabs on isolated droplet are fully
capable of recruiting EE.
To see if Rabs on the EE could substitute for those on the
droplet, we removed Rabs from the droplet with RabGDI and
then assayed for the recruitment of the EE marker EEA1
(Fig. 4D). Untreated droplets recruited some early endosomes inthe absence of GTPγs but the amount was markedly increased
when GTPγs was present (compare lane 2 with 4). The presence
of ATP in the mixture actually caused a decrease in EE
recruitment (lane 3). Droplets that lacked detectable Rabs
(lane 5) were still able to bind both EEA1 and Rab5 when
mixed with isolated early endosomes plus GTPγs, but recruit-
ment was blunted compared to the control (compare lane 8 with
lane 4). While Rabs on the EE may be able to control EE
interaction with droplets, these interactions work more effi-
ciently when Rabs are on the droplets. Lane 9 shows that isolated
early endosomes contain EEA1 and Rab5.
These experiments do not rule out the possibility that a GTP
binding protein other than the Rabs is required for EE
recruitment to droplets. Therefore, we prepared droplets and
EE and pretreated them both with RabGDI to remove Rabs
(Fig. 4E). We then used a cytosol-free mixture to compare the
ability of Rab depleted droplets and EE to interact (lanes 5–8)
relative to untreated samples (lanes 1–4). With the untreated
samples, EE binding to droplets increased with the addition of
GTPγs (compare lane 1 with 3) but not ATP (lane 2). By contrast,
virtually no increase in binding occurred in Rab-depleted
samples incubated in the presence of EE and GTPγs. We noted
in this and other experiments that ATP caused the dissociation of
EE from the droplets (lane 2). Indeed, the addition of ATP and
GTPγs together blocked the recruitment of EE to the droplet
(lane 4). Non-hydrolyzable ATP would not substitute for ATP
(data not shown), indicating that ATP hydrolysis was required
for this effect. We also found that ATP stimulated the
dissociation of EE that had pre-bound to the droplet (data not
shown). Finally, the binding of EE to droplets was not inhibited
by N-ethyl-maleimide (NEM) or EDTA (data not shown).
3.3. Rab5 will recruit EEA1 to droplets in vivo
The in vitro experiments suggest that Rab GTPases can
regulate the interaction between early endosomes and lipid
filled adiposomes. To more firmly establish that the in vitro
interaction we characterized reflects a potential in vivo activity
of the droplets, we carried out experiments to determine if Rab5
can regulate the interaction of early endosomal markers withFig. 4. GTP-dependent recruitment of early endosomes (EE) to droplets in vitro.
Purified droplets (50 μl, ∼20 μg of protein/reaction) were incubated with EE
(50 μl, 5 μg of protein/reaction) at 37 °C for 1 h in the presence or absence of
2 mM GTPγs, cytosol or ATP. At the end of the reaction, free EE was separated
from bound EE by flotation of droplets, and the droplet fraction subsequently
washed three times with buffer B by repeated centrifugation at 10,000×g.
Samples were processed for immunoblotting as described. (A) GTPγs-dependent
recruitment of EE to droplets does not require the presence of cytosol. (B) EE
recruitment to droplets is dependent on concentration of EE (50 μl of droplets,
plus 2 mM GTPγs and the indicated amount of EE). All incubations were at
37 °C for 1 h. (C) Pretreatment of droplets with GTPγs supports EE recruitment.
(D) The Rabs on the EE are sufficient to recruit EE to droplets. Droplets were
treated with 10 μM RabGDI for 1 h to remove Rabs. These droplets were then
mixed with EE and incubated in the presence of the indicated nucleotide for 1 h
at 37 °C. Lane 9 is a sample of EE (1.25 μg). (E) Rabs are necessary for
recruitment of EE. Both droplets and EE were treated to remove Rabs with
RabGDI. These fractions were then mixed in the presence of the indicated
nucleotide (2 mM) and incubated for 1 h at 37 °C.
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that the interactions between droplets and endosomes would be
regulated and, therefore, difficult to detect without experi-
mental manipulation. Therefore, to determine if droplets are
able to engage endosomal markers in situ, we constructed two
cDNAs, one coding for activated Rab5Q79L and the other for
inactivate Rab5S34N (Fig. 5). The two Rab5 constructs lacked a
C-terminal CAAX box but contained an N-terminal 73 amino
acid extension that we have established targets and anchors
proteins specifically on the droplet [23]. HeLa cells were
transiently transfected with the cDNA for these proteins and
processed for immunofluorescence staining of the Myc-tag
(Rab5) and endogenous EEA1. In non-transfected cells, α-
EEA1 IgG gave a characteristic punctate staining pattern
indicative of endosomal staining (data not shown). The
Rab5Q79L and Rab5S34N expressed in cells were primarily
located on the periphery of droplets (Fig. 5A, D, G). EEA1 in
cells expressing 5S34N had a normal punctate staining pattern
that was dispersed in the cell and not associated with the
droplets (G–I). In Rab5Q79L expressing cells, by contrast,
EEA1 had a punctate staining pattern but the puncta wereFig. 5. Recruitment of EEA1 to droplets in vivo. We transfected HeLa cells with cDN
(G–I) chimeric proteins. The cells were incubated for 15 h in media containing 100
immunofluorescence localization of Myc. Both chimeric proteins efficiently targeted
distinct sites on the droplet (C, F). EEA1 was largely depleted from other sites withi
punctate distribution (H) that was not associated with the droplet (I). The scale bar,almost exclusively associated with droplets (A–F). We saw
very little endosomal EEA1 elsewhere in these cells, which
suggests that under these conditions most of the EEA1 in the
cells is bound to the Rab5Q79L on the droplet. We conclude that
the monolayer surrounding each droplet supports the Rab5-
dependent, GTP-regulated interaction of endosomal maker
proteins.
4. Discussion
Rabs are generally thought to be involved in regulating the
movement and interactions of specific membrane systems. For
example, Rab5 regulates the traffic and interaction of early
endosomes [31] by a mechanism that depends on the presence
of Rab5 in this membrane compartment [29]. Therefore, the
appearance of multiple Rab species in isolated lipid droplets
raises important questions about the function of these
regulatory proteins in lipid homeostasis. Is the adiposome a
promiscuous organelle that normally interacts with multiple
membrane systems or do Rabs have novel functions in this
compartment that do not fit standard paradigms? The results ofAs coding for either the Myc-tagged Rab5Q79L (A–F) or Myc-tagged Rab5S34N
μM oleic acid to induce lipid droplets and then fixed and processed for indirect
droplets (A, D, G). Rab5Q79L (A, D) caused the recruitment of EEA1 (B, E) to
n these cells. By contrast, in cells expressing Rab5S34N (G) EEA1 had a normal
1 μm.
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may be to regulate membrane traffic to this organelle.
4.1. Rabs on adiposomes are potentially functional
Immunogold EM showed that three Rab species (Rab5, 11,
18) detected by immunoblotting in the droplet fractions are
located on the surface of the organelle and not on contaminating
membranes. Our first concern was that the phospholipid
monolayer surrounding the droplet might non-specifically
bind prenylated proteins during the isolation procedure. We
carried out multiple tests to rule out this possibility. Rab GDP-
dissociation inhibitor (RabGDI) removed multiple Rabs from
the droplet, which was inhibited by GTPγs. RabGDI did not
remove Ral B, another prenylated protein in the droplets.
Unexpectedly, RabGDI also did not remove Rab18, suggesting
this Rab is anchored to the droplet by a different mechanism
than simply prenylation. In addition to RabGDI removing
specific Rab species in a GDP-dependent step, multiple Rabs
(but not Rab18) rebound to Rab-depleted droplets incubated in
the presence of cytosol plus GTPγs. Binding of each Rab
species seemed to be independent of the other, suggesting each
Rab species binds to a specific site. Finally, coordinate with the
recruitment of Rabs from the cytosol to the droplet, the Rab5
effector EEA1 also appeared on the droplet. These results
suggest that the Rabs in purified droplets may be functional
within the cell.
To directly test for the functionality of the Rabs in the
isolated droplets, we used an in vitro assay. We prepared
fractions of droplets and early endosomes and allowed them to
interact under defined conditions. The droplets were then re-
isolated and assayed for the presence of the EE markers EEA1
and transferrin receptor. Interaction between the two organelles
had several unique characteristics; binding of EEs wasFig. 6. Transient Inter-Compartmental Contact Sites (TICCS) mediate lipid traffic bet
movement of a lipid cargo such as membrane sterol (yellow) between the cell surfa
bidirectional and depends on the formation endosome–endosome as well as endos
molecular machinery necessary for the formation of TICCS. Compartmental specifidependent on 37 °C, the presence of Rabs, GTPγs but not
cytosol. When we increased the concentration of EE protein in
the mixture, there was an increase in EE binding to the droplet
that plateaued at ∼40 μg/ml of EE. This suggests there are
specific binding sites on the droplet for EE. EE binding to the
droplets was not abolished by removing Rabs selectively from
droplets, which indicates Rabs may only need to be present on
one or the other of the two interacting compartments for
interaction to occur. Finally, ATP, but not ATPγs, blocked EE
binding and caused the dissociation of pre-bound EE, which is
additional evidence that EE interaction with adiposomes
involves specific molecular machinery. The effect of ATP
may mean a kinase on either the droplet or the early endosome
regulates the interaction between the two compartments.
Both the recruitment of EEA1 from the cytosol and the
regulated interaction with EE suggests that the Rabs on the
surface of the droplet are functional. In support of this
conclusion, we found that Rab5-GTP is capable of recruiting
EE markers to droplets in living cells. Rather than simply
overexpressing dominant inactive and active Rab5 and risk
disruption of membrane traffic, we decided to target Rab5
constructs to the droplet and see if any known Rab5-interacting
components now bind. Droplets containing Rab5Q79L robustly
recruited EEA1, while those coated with Rab5S34N did not.
EEA1 staining on the droplet had a punctate appearance, similar
in size and morphology to EE in non-transfected cells.
Nevertheless, transferrin and transferrin receptor were not
detected with the EEA1 on the droplet. This is consistent with
our finding that the interaction of transferrin receptor positive
EE with the droplets in vitro is tightly regulated by ATP, which
may make it difficult to detect transferrin-positive EE traffic to
the droplet-associated population of EEA1. Alternatively, the
massive relocation of EEA1 to the droplet may have disrupted
the membrane traffic of endosomes containing transferrinween membrane compartments and lipid filled adiposomes. Here depicted is the
ce and lipid droplets using endosomal intermediates. Migration of the sterol is
ome-droplet TICCS. Recognition sites (red) for each compartment contain the
city of TICCS formation is regulated by Rab-GTP.
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that the phospholipid monolayer surrounding the neutral lipid
core of each droplet is able to engage EEA1 in a Rab-GTP
dependent reaction. This is significant because Rab-GTP
mediated binding of EEA1 to endosomes depends on an
interaction between the FYVE motif in EEA1 and PI3P [32],
which implies that, like endosomes, droplets are able to recruit
the PI3K necessary for PI3P synthesis. Indeed, Yu et al. have
reported that isolated droplets contain a PI3K [33].
4.2. Endosome–adiposome interaction during lipid traffic
The interaction between endosomes and lipid filled adipo-
somes appears to be different from what occurs during
endosome–endosome fusion in vitro [23], but, nevertheless,
has the hallmarks of a membrane kiss and run event. Rather than
fusion and fission, however, the interaction we detected appears
to be transient and involve a regulated docking step without
subsequent membrane fusion. Based on what is known about
endosome–endosome fusion, docking of EE on adiposomes
may use EEA1 as a tethering factor [34]. EEA1 mediated
endosome–endosome docking is not inhibited by ATPγs [34].
We also found that endosome–adiposome docking was not
sensitive to ATPγs. During endosome–endosome fusion, the
presence of ATP leads to fusion of endosomes in an NSF
dependent step [34]. By contrast, the presence of ATP caused
EE to dissociate from adiposomes and docking was insensitive
to NEM (data not shown). EE docking may occur without
fusion because droplets are covered by a phospholipid
monolayer that is expected to be a poor substrate for
membrane–membrane fusion. Nevertheless, we cannot rule
out the possibility that under some conditions hemifusion
occurs between the adiposome monolayer and the outer leaflet
of the endosome or that adiposomes do not contain the
molecular machinery required for fusion.
We speculate that each Rab species on the adiposome
regulates interaction with a specific membrane system. For
example, Rab5 controls interaction with EE and Rab18 with ER
[20]. Mitochondria [27,35] and peroxisomes [36] are also
known to interact with droplets so there may be Rab species
specific for these two compartments too. In support of this
speculation, recent proteomic studies have determined that like
adiposomes both purified synaptic vesicles [37] and purified
secretory membranes [38] contain multiple Rab species. The
interaction of adiposomes with different membrane systems
may be part of a network of transient inter-compartmental
contact sites (TICCS) that are critical for transferring lipids,
small molecules and ions without membrane fusion (reviewed
in [39]). There may be both common and specific machinery for
bringing together each set of membrane compartments. For
example, TICCS may be involved in the interaction of ER
subdomains with mitochondria and the transfer of phosphati-
dylserine (PtdSer) for conversion to phosphatidylethanolamine
(PtdEtn) [40]. A similar interaction occurs between ER and
plasma membrane, which also appears to be important for lipid
transfer [41,42]. TICCS may also mediate interactions between
adiposomes and peroxisomes [36]. Recent studies suggest howTICCS might work (Fig. 6). Sterols can move from the cell
surface through endosomal membranes to lipid droplets and
back by an ATP independent pathway [43]. The binding of EE
to droplets also does not require ATP, which raises the
possibility that a series of TICCS, which can connect together
multiple endosomal compartments, allows the passage of sterols
from the cell surface to the droplet without expending energy.
The physiologic significance of connecting together internal
membranes in this way is to allow rapid, bi-directional,
regulated movement of cholesterol between HDL (and other
lipoproteins) bound to SR-B1 at the cell surface and internal
compartments. [44]. Identifying the molecular basis of TICCS
function is an important future goal that is very approachable
using endosome–adiposome interaction as a model system.
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